Insight Molecular Diagnostics, Inc. (IMDX)
5.85
+0.13
(+2.27%)
USD |
NASDAQ |
Jun 09, 16:00
5.83
-0.02
(-0.34%)
After-Hours: 20:00
Insight Molecular Diagnostics EPS Diluted (Quarterly) : -0.1243 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Precigen, Inc. | -0.0224 |
| Agenus, Inc. | 1.023 |
| Amgen, Inc. | 3.344 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
| Imunon, Inc. | -0.8449 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.29M |
| Revenue (Quarterly) | 0.032M |
| Total Expenses (Quarterly) | 4.322M |
| Enterprise Value | 163.01M |
| Gross Profit Margin (Quarterly) | -1.89K% |
| Profit Margin (Quarterly) | -13.41K% |
| Earnings Yield | -25.35% |
| Normalized Earnings Yield | -20.06 |